IRCCS Casa Sollievo della Sofferenza Hospital, 71013 San Giovanni Rotondo, Italy.
Leuk Res. 2011 Mar;35(3):363-8. doi: 10.1016/j.leukres.2010.08.010. Epub 2010 Sep 28.
Regulatory T-cells (Treg) actively maintain immunological self-tolerance and play a significant role in the progression of cancer. Treg cell numbers have been evaluated in 80 patients with previously untreated chronic lymphocytic leukemia (CLL) and in 40 normal healthy volunteers. Treg cells are higher in CLL patients than in controls and correlate with disease status (more advanced clinical stage, peripheral blood B-cell lymphocytosis, absolute CD38+ B-cell number, and more elevated LDH levels). No correlation was found with ZAP-70 expression, IgVH mutational status and cytogenetic abnormalities. This data shows that Treg cell number is abnormal in CLL patients.
调节性 T 细胞(Treg)积极维持免疫自身耐受,并在癌症的进展中发挥重要作用。评估了 80 例未经治疗的慢性淋巴细胞白血病(CLL)患者和 40 例正常健康志愿者的 Treg 细胞数量。CLL 患者的 Treg 细胞高于对照组,且与疾病状态相关(更晚期的临床分期、外周血 B 细胞淋巴细胞增多、绝对 CD38+B 细胞数量和更高的 LDH 水平)。与 ZAP-70 表达、IgVH 突变状态和细胞遗传学异常无关。这些数据表明 CLL 患者的 Treg 细胞数量异常。